Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 3.51% | 52.43 | 0.9% | $1363.76m | |
| JNJ | Johnson & Johnson | 1.74% | 176.97 | 0.7% | $1352.49m | |
| BMY | Bristol-Myers Squibb Co. | 0.36% | 76.23 | 1.0% | $1197.90m | |
| ABBV | AbbVie, Inc. | -0.53% | 150.92 | 1.9% | $1137.44m | |
| MRK | Merck & Co., Inc. | 1.26% | 93.25 | 0.7% | $1136.00m | |
| LLY | Eli Lilly & Co. | 4.49% | 299.11 | 1.1% | $892.99m | |
| AZN | AstraZeneca Plc | 2.59% | 66.21 | 1.0% | $517.65m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 0.65% | 141.96 | 0.0% | $458.27m | |
| VERU | Veru, Inc. | -6.37% | 13.38 | 0.0% | $318.66m | |
| NVS | Novartis AG | 0.86% | 89.41 | 0.2% | $251.17m | |
| GSK | GlaxoSmithKline Plc | 2.23% | 44.53 | 0.2% | $243.21m | |
| HZNP | Horizon Therapeutics Plc | 1.13% | 90.35 | 5.4% | $200.40m | |
| NVO | Novo Nordisk A/S | 3.49% | 107.68 | 0.1% | $190.60m | |
| SGEN | Seagen Inc. | -2.10% | 139.64 | 5.7% | $181.75m | |
| VTRS | Viatris, Inc. | 0.94% | 11.80 | 0.0% | $166.13m |
Company Profile
Pulmatrix, Inc. is a clinical stage biotechnology company engaged in the discovery and development of novel inhaled therapeutic products for respiratory and other diseases. The firm focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov, and Robert S. Langer, Jr. on June 15, 2015 and is headquartered in Lexington, MA.